Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOLOGIA, ANTIRRETROVIRAIS, SANGUE, CORDÃO UMBILICAL, VÍRUS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Rodrigo Metzker Pereira et al. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women. British Journal of Clinical Pharmacology, v. 84, n. 10, p. 2415-2421, 2018Tradução . . Disponível em: https://doi.org/10.1111/bcp.13700. Acesso em: 09 nov. 2024.APA
Ribeiro, R. M. P., Moreira, F. de L., Moisés, E. C. D., Cavalli, R. de C., Quintana, S. M., Lanchote, V. L., & Duarte, G. (2018). Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women. British Journal of Clinical Pharmacology, 84( 10), 2415-2421. doi:10.1111/bcp.13700NLM
Ribeiro RMP, Moreira F de L, Moisés ECD, Cavalli R de C, Quintana SM, Lanchote VL, Duarte G. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 10): 2415-2421.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1111/bcp.13700Vancouver
Ribeiro RMP, Moreira F de L, Moisés ECD, Cavalli R de C, Quintana SM, Lanchote VL, Duarte G. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 10): 2415-2421.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1111/bcp.13700
